Questions a plan sponsor actually asks.
What is Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine and Amphetamine Aspartate used for?
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine and Amphetamine Aspartate is a this drug class medication tracked in Medicare Part D.
Is there a generic for Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine and Amphetamine Aspartate?
No. Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine and Amphetamine Aspartate is brand-only with no generic equivalents currently in market.
How much does my plan pay for Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine and Amphetamine Aspartate?
Across 329 Part D plans, Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine and Amphetamine Aspartate averages $3.67/unit (NADAC). Lowest available: $0.474/unit. Highest in distribution: $6.81/unit.
Is Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine and Amphetamine Aspartate on the FDA shortage list?
No. Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine and Amphetamine Aspartate is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (12 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.